Cargando…
Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
The aim of this study was to examine the risk of falls associated with the use of non-gamma amino butyric acid (GABA) sleep medications, suvorexant and ramelteon. This case-control and case-crossover study was performed at the Kudanzaka Hospital, Chiyoda Ward, Tokyo. A total of 325 patients who had...
Autores principales: | Ishibashi, Yoshiki, Nishitani, Rie, Shimura, Akiyoshi, Takeuchi, Ayano, Touko, Mamoru, Kato, Takashi, Chiba, Sahoko, Ashidate, Keiko, Ishiwata, Nobuo, Ichijo, Tomoyasu, Sasabe, Masataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486134/ https://www.ncbi.nlm.nih.gov/pubmed/32916693 http://dx.doi.org/10.1371/journal.pone.0238723 |
Ejemplares similares
-
Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
por: Ishibashi, Yoshiki, et al.
Publicado: (2021) -
Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015) -
Suvorexant, a Dual Orexin Receptor Antagonist, Protected Seizure through Interaction with GABA(A) and Glutamate Receptors
por: Razavi, Bibi Marjan, et al.
Publicado: (2020) -
PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016) -
Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)